Isolated type 5 antimitochondrial autoantibodies are associated with a history of thrombocytopenia and fetal loss

Fertil Steril. 2007 Apr;87(4):976.e17-8. doi: 10.1016/j.fertnstert.2006.07.1535. Epub 2007 Jan 12.

Abstract

Objective: To report an unusual case of clinical antiphospholipid syndrome seen with recurrent fetal loss, chronic thrombocytopenia, and recurrent idiopathic thrombocytopenic purpura, in which the only laboratory marker was M5-type antimitochondrial autoantibodies (AMA).

Design: Case report.

Setting: University general hospital, tertiary level of clinical care. Institutional practice.

Patient(s): A 65-year-old woman with antiphospholipid syndrome associated with autoimmune polyglandular syndrome of IIIC type.

Intervention(s): Clinical history and biochemical and immunologic markers.

Main outcome measure(s): The presence of M5-type AMA in clinical antiphospholipid syndrome isolated by indirect immunofluorescence.

Result(s): During the 10-year follow-up, immunologic studies detected a persistent positive M5-type AMA at high titer (1/640), antithyroid antibodies, anti-gastric parietal cells, and anti-intrinsic factor. Antinuclear, anti-DNA, and antiphospholipid (anticardiolipin, anti-beta(2)-glycoprotein I) autoantibody tests were all repeatedly negative. Results of coagulation studies and negative lupus anticoagulant were normal on several occasions.

Conclusion(s): Our findings suggest the necessity of determining M5-type AMA in the study panel of antiphospholipid syndrome diagnosis, particularly in the absence of other typical autoantibodies.

Publication types

  • Case Reports

MeSH terms

  • Abortion, Habitual / etiology*
  • Aged
  • Antiphospholipid Syndrome / complications*
  • Autoantibodies / blood*
  • Chronic Disease
  • Female
  • Humans
  • Mitochondria / immunology*
  • Purpura, Thrombocytopenic, Idiopathic / etiology
  • Recurrence
  • Thrombocytopenia / etiology*

Substances

  • Autoantibodies